The most important thing for preparing the ALS-Con-201 exam is reviewing the essential point. Some students learn all the knowledge of the test. They still fail because they just remember the less important point. In order to service the candidates better, we have issued the ALS-Con-201 test engine for you. Our company has accumulated so much experience about the test. So we can predict the real test precisely. Almost half questions and answers of the real exam occur on our ALS-Con-201 practice material. That means if you study our study guide, your passing rate is much higher than other candidates. Preparing the ALS-Con-201 exam has shortcut. From now, stop learning by yourself and try our test engine. All your efforts will pay off one day.
| Section | Objectives |
|---|---|
| Data, Compliance, and Governance | - Compliance and Security
|
| Agentforce and AI Capabilities | - AI and Automation
|
| Customer Engagement and Field Operations | - Territory and Account Management
|
| Agentforce Life Sciences Consulting Fundamentals | - Platform and Solution Architecture
|
>> Reliable ALS-Con-201 Test Pattern <<
We can promise that we will provide you with quality ALS-Con-201 Exam Questions, reasonable price and professional after sale service. Because customer first, service first is our principle of service. If you buy our ALS-Con-201 study guide, you will find our after sale service is so considerate for you. We are glad to meet your all demands and answer your all question about our study materials. And you can find that our price is affordable even for the students. Besides, we will the most professional support by our technicals if you have any problem on buying or downloading.
NEW QUESTION # 92
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?
Answer: B
Explanation:
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.
NEW QUESTION # 93
Choose 1 option.
Cumulus Pharma discovered a gap in the current call-detailing process. While field sales reps are successfully capturing consent for the "Immunexis KOL Webinar Series," some records are submitted without a digital signature. To satisfy strict audit requirements, the company mandates that every consent captured on a mobile device must include a captured signature from the Healthcare Provider (HCP). This requirement must be enforced globally within the Agentforce Life Sciences mobile app, ensuring the signature pad is mandatory during the consent flow.
Which step in the Admin Console should the Agentforce Life Sciences Consultant configure?
Answer: C
Explanation:
The correct answer is B because this is a global mobile consent-capture behavior that should be configured in Consent Administration, not enforced through a custom validation rule or permission workaround. Salesforce Life Sciences Consent Management is used to capture, manage, and track HCP consent for communication channels and subscription preferences. Salesforce's setup guidance for Consent Management directs administrators to the Life Sciences Commercial app, then Admin Console, and then Consent setup areas, which is where consent behavior is configured for the Customer Engagement experience.
The scenario requires that every consent captured on a mobile device include an HCP signature. The appropriate admin configuration is to locate the Signature Section in Consent Administration and set it to Required. This makes the signature pad mandatory during the consent flow and ensures reps cannot submit consent records without capturing the required signature.
Option A is not the best answer because a validation rule on Communication Subscription Consent may block saves after the user attempts submission, but it does not configure the guided mobile consent experience or make the signature pad properly required in the flow. Option C is also incorrect because a custom permission would control access or behavior by profile, but the requirement is global enforcement in the mobile consent flow. Therefore, the consultant should configure the Signature Section as Required in Consent Administration.
=========
NEW QUESTION # 94
Choose 1 option.
A field sales rep bulk deletes several planned visits from the calendar for an upcoming week and then notices that two visits still appear on the calendar.
Why are these visits still visible?
Answer: A
Explanation:
The correct answer is C because Life Sciences Calendar can display visits where the user is not the owner but is included as an attendee or visitor. Salesforce Life Sciences Visit Management supports adding internal users as visitors to a visit so that colleagues participating in the same HCP interaction can be recorded and the visit can be shared with them. Salesforce also describes Life Sciences Calendar as a place to visualize and prioritize key activities, including visits and other events, and Trailhead explains that reps can view colleagues' visits in shared calendars to coordinate engagement.
In this scenario, the rep bulk deleted several planned visits from their calendar. The two remaining visits are likely not visits owned and managed by the rep. Instead, they are visits owned by another user where the rep is included as an attendee. Because the calendar is configured to show attendee visits, those records continue to appear even after the rep deletes their own planned visits.
Option A is incorrect because the issue is not tied to the selected account list. Option B is plausible for some filtered-calendar behavior, but the key clue is that only some visits remain visible after bulk deletion. The standard Life Sciences explanation is that attendee visits can remain visible because they belong to a colleague and are displayed for collaboration. Therefore, the visits remain because the rep is added as an attendee.
=========
NEW QUESTION # 95
Choose 1 option.
When sending email using the Agentforce Life Sciences mobile app, who can field sales reps CC on the message?
Answer: C
Explanation:
The correct answer is A because Salesforce Life Sciences Field Email allows field users to add colleagues as CC recipients. Salesforce Help for customizing and sending emails in Life Sciences Cloud states that users can send emails to healthcare professionals and healthcare organizations from their workflow, select an email template, and add colleagues as CC recipients.
This distinction matters for compliance. In Life Sciences engagement, HCPs and HCOs are the intended external recipients of approved email communications. The CC field is not intended as a free-form way to add additional HCPs. Instead, CC is used for internal collaboration or visibility, such as copying a colleague involved in the account, territory, or follow-up process. This helps keep HCP communications controlled, trackable, and aligned with approved email workflows.
Option B is incorrect because it suggests both HCPs and colleagues can be CC'd. Although emails are sent to HCPs or HCOs, Salesforce's documented CC behavior specifically references colleagues as CC recipients. Option C is also incorrect because HCPs are the primary external recipients, not the users who should be copied in the CC field. Therefore, when sending email from the Agentforce Life Sciences mobile app, field sales reps can CC colleagues.
=========
NEW QUESTION # 96
Choose 1 option.
Cumulus Pharma wants to customize the provider summary to include additional information stored in Agentforce Life Sciences for Customer Engagement. An Agentforce Life Sciences Consultant updated the Actionable Relationship Center (ARC) graph used in provider summarization to include additional objects and fields.
How should the consultant ensure that Provider Summary Generation uses the new information to meet business goals?
Answer: C
Explanation:
The correct answer is A because provider summary generation depends on the prompt template and the data supplied to that prompt. In Life Sciences Cloud account summarization, Salesforce documentation references custom prompt templates for account summarization and the account summarization workflow, while the workflow uses the Generate Provider Account Territory Summary flow as part of the summary-generation process. Salesforce also documents that this flow calls actions such as Get Object Relationship Data and Get Life Sciences Configuration Field Names, meaning the flow participates in retrieving relationship-based data, but the generated business summary still needs the prompt template to know what information to use and how to summarize it.
Updating the ARC graph alone makes additional objects and fields available in the relationship structure, but it does not automatically change the prompt's summarization behavior. To ensure the new information is used correctly, the consultant should create a new prompt template version, update the input dataset so the new fields are included, revise the summarization instructions so the AI knows how to use them, and then activate that version. This aligns with Salesforce's guidance that prompt-based generation relies on the configured prompt and its grounding/input data. Option B is incomplete because changing only the flow does not update the prompt's instructions. Option C is also incorrect because batch-job configuration controls bulk execution, not the actual summarization logic.
NEW QUESTION # 97
......
We are steely to be the first-rank ALS-Con-201 practice materials in this area. On your way to success, we are the strong backups you can depend on. We have confidence that your career will be in the ascendant with the passing certificate of the ALS-Con-201 Study Guide as a beginning. With the unbeatable high pass rate as 98% to 100%, no one can do this job better than us to help you pass the ALS-Con-201 exam. Just give you a chance to success!
Exams ALS-Con-201 Torrent: https://www.vce4dumps.com/ALS-Con-201-valid-torrent.html